Intrinsic value of Amyris - AMRS

Previous Close

$4.09

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

  Value-price divergence*

0%

Previous close

$4.09

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

 
Value-price divergence*

0%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of AMRS stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.1

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  97.06
  44.40
  40.46
  36.91
  33.72
  30.85
  28.27
  25.94
  23.84
  21.96
  20.26
  18.74
  17.36
  16.13
  15.01
  14.01
  13.11
  12.30
  11.57
  10.91
  10.32
  9.79
  9.31
  8.88
  8.49
  8.14
  7.83
  7.55
  7.29
  7.06
  6.86
Revenue, $m
  67
  97
  136
  186
  249
  326
  418
  526
  651
  794
  955
  1,134
  1,331
  1,546
  1,778
  2,027
  2,293
  2,575
  2,873
  3,187
  3,516
  3,860
  4,219
  4,594
  4,984
  5,390
  5,812
  6,250
  6,706
  7,179
  7,672
Variable operating expenses, $m
 
  524
  736
  1,008
  1,348
  1,763
  2,262
  2,849
  3,528
  4,302
  5,174
  6,144
  7,211
  8,373
  9,631
  10,980
  12,420
  13,948
  15,562
  17,260
  19,042
  20,906
  22,853
  24,882
  26,995
  29,193
  31,478
  33,854
  36,322
  38,887
  41,553
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  167
  524
  736
  1,008
  1,348
  1,763
  2,262
  2,849
  3,528
  4,302
  5,174
  6,144
  7,211
  8,373
  9,631
  10,980
  12,420
  13,948
  15,562
  17,260
  19,042
  20,906
  22,853
  24,882
  26,995
  29,193
  31,478
  33,854
  36,322
  38,887
  41,553
Operating income, $m
  -100
  -427
  -600
  -822
  -1,099
  -1,438
  -1,844
  -2,323
  -2,876
  -3,508
  -4,219
  -5,009
  -5,879
  -6,828
  -7,853
  -8,953
  -10,127
  -11,373
  -12,689
  -14,074
  -15,526
  -17,046
  -18,633
  -20,288
  -22,011
  -23,803
  -25,667
  -27,604
  -29,616
  -31,708
  -33,881
EBITDA, $m
  -89
  -419
  -589
  -806
  -1,078
  -1,410
  -1,809
  -2,278
  -2,821
  -3,440
  -4,138
  -4,913
  -5,766
  -6,696
  -7,701
  -8,781
  -9,932
  -11,154
  -12,444
  -13,802
  -15,227
  -16,718
  -18,274
  -19,897
  -21,587
  -23,345
  -25,172
  -27,072
  -29,045
  -31,097
  -33,229
Interest expense (income), $m
  10
  11
  3
  7
  12
  18
  26
  35
  46
  58
  72
  88
  106
  126
  147
  170
  195
  222
  250
  279
  311
  343
  378
  413
  451
  490
  530
  572
  616
  661
  708
Earnings before tax, $m
  -97
  -439
  -603
  -829
  -1,111
  -1,456
  -1,870
  -2,357
  -2,922
  -3,566
  -4,291
  -5,098
  -5,986
  -6,953
  -8,000
  -9,123
  -10,322
  -11,594
  -12,938
  -14,353
  -15,837
  -17,390
  -19,011
  -20,702
  -22,462
  -24,293
  -26,197
  -28,176
  -30,232
  -32,369
  -34,590
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -97
  -439
  -603
  -829
  -1,111
  -1,456
  -1,870
  -2,357
  -2,922
  -3,566
  -4,291
  -5,098
  -5,986
  -6,953
  -8,000
  -9,123
  -10,322
  -11,594
  -12,938
  -14,353
  -15,837
  -17,390
  -19,011
  -20,702
  -22,462
  -24,293
  -26,197
  -28,176
  -30,232
  -32,369
  -34,590

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  29
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  130
  188
  264
  361
  483
  632
  811
  1,021
  1,265
  1,542
  1,855
  2,202
  2,585
  3,002
  3,452
  3,936
  4,452
  5,000
  5,579
  6,188
  6,826
  7,495
  8,192
  8,920
  9,677
  10,465
  11,285
  12,136
  13,021
  13,940
  14,896
Adjusted assets (=assets-cash), $m
  101
  188
  264
  361
  483
  632
  811
  1,021
  1,265
  1,542
  1,855
  2,202
  2,585
  3,002
  3,452
  3,936
  4,452
  5,000
  5,579
  6,188
  6,826
  7,495
  8,192
  8,920
  9,677
  10,465
  11,285
  12,136
  13,021
  13,940
  14,896
Revenue / Adjusted assets
  0.663
  0.516
  0.515
  0.515
  0.516
  0.516
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
  0.515
Average production assets, $m
  57
  82
  116
  158
  212
  277
  355
  448
  554
  676
  813
  965
  1,133
  1,316
  1,513
  1,725
  1,951
  2,191
  2,445
  2,712
  2,992
  3,285
  3,590
  3,909
  4,241
  4,587
  4,946
  5,319
  5,707
  6,110
  6,528
Working capital, $m
  -51
  -10
  -14
  -19
  -25
  -33
  -42
  -53
  -65
  -79
  -96
  -113
  -133
  -155
  -178
  -203
  -229
  -258
  -287
  -319
  -352
  -386
  -422
  -459
  -498
  -539
  -581
  -625
  -671
  -718
  -767
Total debt, $m
  195
  50
  118
  206
  316
  450
  611
  800
  1,019
  1,269
  1,550
  1,863
  2,207
  2,583
  2,988
  3,424
  3,888
  4,381
  4,902
  5,450
  6,025
  6,626
  7,254
  7,909
  8,591
  9,300
  10,037
  10,803
  11,600
  12,427
  13,288
Total liabilities, $m
  314
  169
  237
  325
  435
  569
  730
  919
  1,138
  1,388
  1,669
  1,982
  2,326
  2,702
  3,107
  3,543
  4,007
  4,500
  5,021
  5,569
  6,144
  6,745
  7,373
  8,028
  8,710
  9,419
  10,156
  10,922
  11,719
  12,546
  13,407
Total equity, $m
  -184
  19
  26
  36
  48
  63
  81
  102
  126
  154
  185
  220
  258
  300
  345
  394
  445
  500
  558
  619
  683
  749
  819
  892
  968
  1,047
  1,128
  1,214
  1,302
  1,394
  1,490
Total liabilities and equity, $m
  130
  188
  263
  361
  483
  632
  811
  1,021
  1,264
  1,542
  1,854
  2,202
  2,584
  3,002
  3,452
  3,937
  4,452
  5,000
  5,579
  6,188
  6,827
  7,494
  8,192
  8,920
  9,678
  10,466
  11,284
  12,136
  13,021
  13,940
  14,897
Debt-to-equity ratio
  -1.060
  2.670
  4.490
  5.710
  6.540
  7.120
  7.530
  7.830
  8.060
  8.230
  8.360
  8.460
  8.540
  8.600
  8.660
  8.700
  8.730
  8.760
  8.790
  8.810
  8.830
  8.840
  8.850
  8.870
  8.880
  8.890
  8.890
  8.900
  8.910
  8.910
  8.920
Adjusted equity ratio
  -2.109
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -97
  -439
  -603
  -829
  -1,111
  -1,456
  -1,870
  -2,357
  -2,922
  -3,566
  -4,291
  -5,098
  -5,986
  -6,953
  -8,000
  -9,123
  -10,322
  -11,594
  -12,938
  -14,353
  -15,837
  -17,390
  -19,011
  -20,702
  -22,462
  -24,293
  -26,197
  -28,176
  -30,232
  -32,369
  -34,590
Depreciation, amort., depletion, $m
  11
  8
  12
  16
  21
  28
  36
  45
  56
  68
  81
  97
  113
  132
  151
  173
  195
  219
  244
  271
  299
  328
  359
  391
  424
  459
  495
  532
  571
  611
  653
Funds from operations, $m
  -71
  -430
  -591
  -813
  -1,089
  -1,428
  -1,834
  -2,313
  -2,867
  -3,499
  -4,210
  -5,001
  -5,872
  -6,822
  -7,849
  -8,951
  -10,127
  -11,375
  -12,694
  -14,082
  -15,538
  -17,061
  -18,652
  -20,311
  -22,038
  -23,834
  -25,702
  -27,644
  -29,661
  -31,758
  -33,937
Change in working capital, $m
  11
  -3
  -4
  -5
  -6
  -8
  -9
  -11
  -13
  -14
  -16
  -18
  -20
  -21
  -23
  -25
  -27
  -28
  -30
  -31
  -33
  -34
  -36
  -37
  -39
  -41
  -42
  -44
  -46
  -47
  -49
Cash from operations, $m
  -82
  -427
  -588
  -808
  -1,083
  -1,420
  -1,825
  -2,302
  -2,854
  -3,484
  -4,194
  -4,983
  -5,853
  -6,800
  -7,825
  -8,926
  -10,101
  -11,347
  -12,664
  -14,050
  -15,505
  -17,027
  -18,616
  -20,273
  -21,999
  -23,794
  -25,660
  -27,600
  -29,616
  -31,710
  -33,888
Maintenance CAPEX, $m
  0
  -6
  -8
  -12
  -16
  -21
  -28
  -36
  -45
  -55
  -68
  -81
  -97
  -113
  -132
  -151
  -173
  -195
  -219
  -244
  -271
  -299
  -328
  -359
  -391
  -424
  -459
  -495
  -532
  -571
  -611
New CAPEX, $m
  -1
  -25
  -33
  -43
  -53
  -65
  -78
  -92
  -107
  -122
  -137
  -152
  -168
  -183
  -198
  -212
  -226
  -240
  -254
  -267
  -280
  -293
  -306
  -319
  -332
  -345
  -359
  -373
  -388
  -403
  -419
Cash from investing activities, $m
  6
  -31
  -41
  -55
  -69
  -86
  -106
  -128
  -152
  -177
  -205
  -233
  -265
  -296
  -330
  -363
  -399
  -435
  -473
  -511
  -551
  -592
  -634
  -678
  -723
  -769
  -818
  -868
  -920
  -974
  -1,030
Free cash flow, $m
  -76
  -458
  -629
  -862
  -1,152
  -1,507
  -1,931
  -2,430
  -3,005
  -3,661
  -4,398
  -5,217
  -6,117
  -7,096
  -8,154
  -9,289
  -10,499
  -11,782
  -13,137
  -14,562
  -16,056
  -17,619
  -19,250
  -20,951
  -22,722
  -24,563
  -26,478
  -28,468
  -30,535
  -32,684
  -34,918
Issuance/(repayment) of debt, $m
  82
  -145
  68
  88
  110
  134
  161
  189
  219
  250
  281
  313
  344
  375
  406
  435
  465
  493
  521
  548
  575
  601
  628
  655
  682
  709
  737
  766
  796
  828
  860
Issuance/(repurchase) of shares, $m
  5
  641
  611
  838
  1,123
  1,471
  1,888
  2,379
  2,946
  3,594
  4,323
  5,133
  6,024
  6,995
  8,045
  9,172
  10,374
  11,649
  12,996
  14,414
  15,901
  17,457
  19,081
  20,774
  22,538
  24,372
  26,279
  28,261
  30,320
  32,461
  34,685
Cash from financing (excl. dividends), $m  
  92
  496
  679
  926
  1,233
  1,605
  2,049
  2,568
  3,165
  3,844
  4,604
  5,446
  6,368
  7,370
  8,451
  9,607
  10,839
  12,142
  13,517
  14,962
  16,476
  18,058
  19,709
  21,429
  23,220
  25,081
  27,016
  29,027
  31,116
  33,289
  35,545
Total cash flow (excl. dividends), $m
  15
  38
  50
  64
  80
  98
  118
  138
  160
  183
  205
  228
  251
  274
  296
  318
  339
  360
  380
  400
  420
  439
  459
  478
  498
  518
  538
  559
  581
  604
  628
Retained Cash Flow (-), $m
  26
  -641
  -611
  -838
  -1,123
  -1,471
  -1,888
  -2,379
  -2,946
  -3,594
  -4,323
  -5,133
  -6,024
  -6,995
  -8,045
  -9,172
  -10,374
  -11,649
  -12,996
  -14,414
  -15,901
  -17,457
  -19,081
  -20,774
  -22,538
  -24,372
  -26,279
  -28,261
  -30,320
  -32,461
  -34,685
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  -603
  -561
  -774
  -1,043
  -1,373
  -1,770
  -2,240
  -2,786
  -3,411
  -4,117
  -4,904
  -5,773
  -6,721
  -7,749
  -8,854
  -10,035
  -11,289
  -12,616
  -14,014
  -15,481
  -17,017
  -18,622
  -20,296
  -22,040
  -23,854
  -25,740
  -27,701
  -29,739
  -31,857
  -34,057
Discount rate, %
 
  16.10
  16.91
  17.75
  18.64
  19.57
  20.55
  21.58
  22.65
  23.79
  24.98
  26.23
  27.54
  28.91
  30.36
  31.88
  33.47
  35.14
  36.90
  38.75
  40.68
  42.72
  44.85
  47.10
  49.45
  51.92
  54.52
  57.25
  60.11
  63.11
  66.27
PV of cash for distribution, $m
 
  -520
  -410
  -474
  -526
  -562
  -577
  -571
  -544
  -500
  -443
  -378
  -312
  -247
  -189
  -140
  -99
  -67
  -44
  -28
  -17
  -10
  -5
  -3
  -1
  -1
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100
  50.0
  1.5
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and renewable lubricants for industrial applications; and renewable fuels for transportation fuels market. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

FINANCIAL RATIOS  of  Amyris (AMRS)

Valuation Ratios
P/E Ratio -11.6
Price to Sales 16.7
Price to Book -6.1
Price to Tangible Book
Price to Cash Flow -13.7
Price to Free Cash Flow -13.5
Growth Rates
Sales Growth Rate 97.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -66.7%
Cap. Spend. - 3 Yr. Gr. Rate -34%
Financial Strength
Quick Ratio 1
Current Ratio 0
LT Debt to Equity -91.3%
Total Debt to Equity -106%
Interest Coverage -9
Management Effectiveness
Return On Assets -73.7%
Ret/ On Assets - 3 Yr. Avg. -66.6%
Return On Total Capital -3233.3%
Ret/ On T. Cap. - 3 Yr. Avg. -1216.5%
Return On Equity 56.7%
Return On Equity - 3 Yr. Avg. 69.9%
Asset Turnover 0.6
Profitability Ratios
Gross Margin 16.4%
Gross Margin - 3 Yr. Avg. 10.3%
EBITDA Margin -113.4%
EBITDA Margin - 3 Yr. Avg. -203.4%
Operating Margin -149.3%
Oper. Margin - 3 Yr. Avg. -282.9%
Pre-Tax Margin -144.8%
Pre-Tax Margin - 3 Yr. Avg. -252.4%
Net Profit Margin -144.8%
Net Profit Margin - 3 Yr. Avg. -260.4%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 5.4%
Payout Ratio 0%

AMRS stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the AMRS stock intrinsic value calculation we used $67 million for the last fiscal year's total revenue generated by Amyris. The default revenue input number comes from 2016 income statement of Amyris. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our AMRS stock valuation model: a) initial revenue growth rate of 44.4% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 16.1%, whose default value for AMRS is calculated based on our internal credit rating of Amyris, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Amyris.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of AMRS stock the variable cost ratio is equal to 541.8%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for AMRS stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.7% for Amyris.

Corporate tax rate of 27% is the nominal tax rate for Amyris. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the AMRS stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for AMRS are equal to 85.1%.

Life of production assets of 10 years is the average useful life of capital assets used in Amyris operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for AMRS is equal to -10%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $-184 million for Amyris - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 260.677 million for Amyris is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Amyris at the current share price and the inputted number of shares is $1.1 billion.

RELATED COMPANIES Price Int.Val. Rating
TOT Total ADR 49.62 10.00  str.sell
GEVO Gevo 0.690 1.18  str.buy
ALB Albemarle 118.34 63.44  sell
XOM Exxon Mobil 80.12 102.38  buy
VLO Valero Energy 67.78 2,056.36  str.buy
HFC HollyFrontier 27.32 4,244.87  str.buy
MPC Marathon Petro 55.34 684.21  str.buy

COMPANY NEWS

▶ Amyris reports 1Q loss   [May-15-17 06:38PM  Associated Press]
Stock chart of AMRS Financial statements of AMRS Annual reports of AMRS
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.